Free Trial
ASX:AGN

Argenica Therapeutics (AGN) Stock Price, News & Analysis

About Argenica Therapeutics Stock (ASX:AGN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
$104.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Argenica Therapeutics Limited engages in the research and development of a neuroprotective therapeutic drug in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate use to protect brain cells and reduce cell death during a stroke and other types of neural injuries. Argenica Therapeutics Limited was incorporated in 2019 and is based in Nedlands, Australia.

Receive AGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Argenica Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

AGN Stock News Headlines

Argenica Therapeutics Ltd Ordinary Shares AGN
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?
Argenica Therapeutics Limited (AGN.AX)
Argenica Therapeutics Insider Ups Holding During Year
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
Insurance
Current Symbol
ASX:AGN
CIK
N/A
Fax
N/A
Employees
22,300
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-5,480,000.00
Net Margins
-238.05%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.60 million
Price / Cash Flow
N/A
Book Value
A$0.13 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$104.40 million
Optionable
Not Optionable
Beta
0.79
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (ASX:AGN) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners